An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer.
Hawkins O, Verma B, Lightfoot S, Jain R, Rawat A, McNair S, Caseltine S, Mojsilovic A, Gupta P, Neethling F, Almanza O, Dooley W, Hildebrand W, Weidanz J.
Hawkins O, et al. Among authors: neethling f.
J Immunol. 2011 Jun 1;186(11):6607-16. doi: 10.4049/jimmunol.1003995. Epub 2011 Apr 22.
J Immunol. 2011.
PMID: 21515791